<!DOCTYPE html>
<html lang="en">
  <head>

    <title>RPC Rounds | Best Ophthalmology Blog for Residents & Fellows</title>
    <link rel='icon' href='favicon.ico' type='image/x-icon'/>
<meta name="viewport" content="width=device-width, initial-scale=1">
<!-- below is facebook og -->
<meta property="og:url"           content="https://www.sadbhaavclinic.com/gradings.html" />
<meta property="og:type"          content="article" />
<meta property="og:title"         content="RPC Rounds | Gradings & Stagings in Ophthalmology" />
<meta property="og:description"   content="Gradings & Stagings in Ophthalmology" />
<meta property="og:image"         content="https://www.sadbhaavclinic.com/images/gradings.jpeg" />
<!-- above is facebook og -->
    <meta charset="utf-8">
    <meta name="Robots" content="all">
    <meta name="Googlebot" content="index, follow">
    <meta name="Yahoobot" content="index, follow">
    <meta name="MSNbot" content="index, follow">
    <meta name="robots" content="Index, Follow">
    <meta name="allow-search" content="yes">
    <meta name="rating" content="General">
    <meta name="document-distribution" content="Global">
    <meta name="language" content="EN">
    <meta name="author" content="Sadbhaav Eye & Dental Clinic">
    <meta name="copyright" content="https://www.sadbhaavclinic.com">
    <meta name="reply-to" content="sadbhaavclinic@gmail.com">
    <meta name="geo.country" content="INDIA">
    <meta name="document-type" content="Public">
    <meta name="document-rating" content="Safe for Kids">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="description" content="This is very useful ophthalmology blog for residents and Fellows">
    <meta name="keywords" itemprop="keywords" content="RPC rounds, Ophthalmology, Blog, Ophthalmology blog,Eye manuals, Eye Books ">


    
    <link href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700&display=swap" rel="stylesheet">

    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">

    <link rel="stylesheet" href="css/animate.css">
    <link rel="stylesheet" href="css/owl.carousel.min.css">
    <link rel="stylesheet" href="css/owl.theme.default.min.css">
    <link rel="stylesheet" href="css/magnific-popup.css">
    
    
    <link rel="stylesheet" href="css/style.css">


<!-- JSON-LD markup generated by Google Structured Data Markup Helper. -->
<script type="application/ld+json">
{
  "@context" : "https://schema.org",
  "@type" : "LocalBusiness",
  "name" : "Sadbhaav Eye & Dental Clinic",
  "telephone" : "+91 701-691-2180",
  "email" : "sadbhaavclinic@gmail.com",
  "address" : {
    "@type" : "PostalAddress",
    "streetAddress" : "SF 5-6, Second Floor, Palladium Business Hub, Opposite PVR Cinema, Above Pantaloons, Visat-Gandhinagar Highway,",
    "addressLocality" : "Motera, Ahmedabad",
    "addressCountry" : "India",
    "postalCode" : "380005"
  },
  "openingHoursSpecification" : {
    "@type" : "OpeningHoursSpecification",
    "dayOfWeek" : {
      "@type" : "DayOfWeek",
      "name" : "Monday to Saturday"
    },
    "opens" : "Please insert valid ISO 8601 date/time here. Examples: 2015-07-27 or 2015-07-27T15:30",
    "closes" : "Please insert valid ISO 8601 date/time here. Examples: 2015-07-27 or 2015-07-27T15:30"
  },
  "url" : "https://www.sadbhaavclinic.com/",
  "aggregateRating" : {
    "@type" : "AggregateRating",
    "ratingValue" : "5",
    "bestRating" : "5",
    "ratingCount" : "200"
  },
  "review" : {
    "@type" : "Review",
    "author" : {
      "@type" : "Person",
      "name" : "Google"
    }
  }
}
</script>
<script src="https://kit.fontawesome.com/8d5cac4b15.js" crossorigin="anonymous"></script> <!-- Fontawesome signed in kit -->
    <!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-101953921-1"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-101953921-1');
</script>
<!-- Google Ads Tag -->
<script data-ad-client="ca-pub-4676392635813919" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>

<script type='text/javascript' src='https://platform-api.sharethis.com/js/sharethis.js#property=5f366fc4be0c1d00127720a2&product=sop' async='async'></script>

  </head>
  <body>

    <div class="wrap">
      <div class="container">
        <div class="row">
          <div class="col-md-9 d-flex align-items-center">
            <p class="mb-0 phone pl-md-2">
              <a href="tel:+917016912180" class="mr-2" title="Call to Sadbhaav Clinic Mobile Number 701-691-2180"><span class="fa fa-phone mr-1"></span> +91 701-691-2180</a> 
              <a href="mailto:sadbhaavclinic@gmail.com" title="Email to sadbhaavclinic@gmail.com"><span class="fa fa-paper-plane mr-1"></span> sadbhaavclinic@gmail.com</a>
              <a href="#" title="Clinic Times are Morning 10:00am to 1:00pm, Evening 5:00pm to 8:00pm (Sunday Closed)"><span class="fa fa-clock-o mr-1"></span> Time: Morning 10:00am to 1:00pm, Evening 5:00pm to 8:00pm (Sunday Closed)</a></p>
          </div>
          <div class="col-md-3 d-flex justify-content-md-end">
            <div class="social-media">
              <p class="mb-0 d-flex">
                <a href="https://www.facebook.com/SadbhaavClinic/" title="SadbhaavClinic Facebook Page" class="d-flex align-items-center justify-content-center"><span class="fa fa-facebook"><i class="sr-only">Facebook</i></span></a>
                <a href="https://twitter.com/sadbhaavclinic" title="SadbhaavClinic on Twitter"class="d-flex align-items-center justify-content-center"><span class="fa fa-twitter"><i class="sr-only">Twitter</i></span></a>
                <a href="https://www.instagram.com/sadbhaavclinic/" title="SadbhaavClinic on Instagram" class="d-flex align-items-center justify-content-center"><span class="fa fa-instagram"><i class="sr-only">Instagram</i></span></a>
                <a href="https://www.linkedin.com/company/sadbhaavclinic/" title="SadbhaavClinic LinkedIn Page" class="d-flex align-items-center justify-content-center"><span class="fa fa-linkedin"><i class="sr-only">LinkedIn</i></span></a>
                <a href="https://in.pinterest.com/sadbhaavclinic/" title="SadbhaavClinic on Pinterest" class="d-flex align-items-center justify-content-center"><span class="fa fa-pinterest"><i class="sr-only">Pinterest</i></span></a>
                <a href="https://api.whatsapp.com/send?phone=917016912180&text=I+need+to+book+an+appointment" title="Message SadbhaavClinic on Whatsapp" class="d-flex align-items-center justify-content-center"><span class="fa fa-whatsapp"><i class="sr-only">whatsapp</i></span></a>
                <a href="https://www.youtube.com/channel/UCn8Oxy6CKxwi9PKAVVgWwcg?view_as=subscriber"class="d-flex align-items-center justify-content-center" title="SadbhaavClinic Youtube channel"><span class="fa fa-youtube"><i class="sr-only">youtube</i></span></a>
              </p>
            </div>
          </div>
        </div>
      </div>
    </div>
    
    <nav class="navbar navbar-expand-lg navbar-dark ftco_navbar bg-dark ftco-navbar-light" id="ftco-navbar">
      <div class="container">
        <a class="navbar-brand" href="ophthalmology.html" title="One of the Best Rated Eye & Dental Clinic in Ahmedabad by AIIMS New Delhi Alumnus">RPC Rounds | Ophthalmology Blog</a>
        <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#ftco-nav" aria-controls="ftco-nav" aria-expanded="false" aria-label="Toggle navigation">
          <span class="oi oi-menu"></span> Menu
        </button>
        <div class="collapse navbar-collapse" id="ftco-nav">
          <ul class="navbar-nav ml-auto">
            <li class="nav-item"><a href="index.html" title="Home Page" class="nav-link">Home</a></li>
            <li class="nav-item"><a href="aboutus.html" title="About us" class="nav-link">About</a></li>
            <li class="nav-item"><a href="eyedepartment.html" title="Eye Department" class="nav-link">Eye</a></li>
            <li class="nav-item"><a href="dentaldepartment.html" title="Dental Department" class="nav-link">Dental</a></li>
            <li class="nav-item"><a href="cases.html" title="Clinical Cases" class="nav-link">Cases</a></li>
            <li class="nav-item"><a href="patientzone.html" title="Patients' Zone" class="nav-link">Patients' Zone</a></li>
            <li class="nav-item active"><a href="ophthalmology.html" title="Patients' Zone" class="nav-link">Ophthalmology Blog</a></li>
            <li class="nav-item"><a href="testimonials.html" title="Testimonials" class="nav-link">Testimonials</a></li>
            <li class="nav-item"><a href="contactus.html" title="Contact us" class="nav-link">Contact</a></li>
          </ul>
        </div>
      </div>
    </nav>
    <!-- END nav -->
    
<br>

    <section class="ftco-section ftco-degree-bg">
      <div class="container">
        <div class="row">
          <div class="col-lg-9 ftco-animate">
          	<p>
              <img src="images/gradings.jpeg" alt="" class="img-fluid">
            </p>
            <h1 class="mb-3" style= "color: orange";>Gradings & Stagings in Ophthalmology</h1>
            <div class="text pl-8">


<h1 style="break-after: avoid; color: red; font-family: Calibri, sans-serif; font-size: 14pt; line-height: 21.4667px; margin: 12pt 0in 3pt;"><a name="_Toc373319666">Grading &amp; Staging</a></h1><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319667">ADA Evidence Grading System for Clinical Practice Recommendations</a><o:p></o:p></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none;"><thead><tr><td style="border: 1pt solid windowtext; padding: 0.75pt;" valign="bottom"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><b><span style="color: #c00000; font-size: 10pt;">Level of evidence<o:p></o:p></span></b></p></td><td style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: none; border-right: 1pt solid windowtext; border-top: 1pt solid windowtext; padding: 0.75pt;" valign="bottom"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><b><span style="color: #006600; font-size: 10pt;">Description<o:p></o:p></span></b></p></td></tr></thead><tbody><tr><td rowspan="3" style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><b><span style="color: #c00000; font-size: 10pt;">A<o:p></o:p></span></b></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><span style="color: #006600; font-size: 10pt;">Clear evidence from&nbsp;<b><i>well-conducted, generalizable, randomized controlled trials</i></b>&nbsp;that are adequately powered, including:<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; text-indent: -0.25in;"><span style="color: #006600; font-family: Symbol; font-size: 10pt;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="color: #006600; font-size: 10pt;">Evidence from a well-conducted multicenter trial<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; text-indent: -0.25in;"><span style="color: #006600; font-family: Symbol; font-size: 10pt;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="color: #006600; font-size: 10pt;">Evidence from a meta-analysis that incorporated quality ratings in the analysis<o:p></o:p></span></p></td></tr><tr><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><span style="color: #006600; font-size: 10pt;">Compelling nonexperimental evidence, i.e., the “all or none” rule developed by the Centre for Evidence-Based Medicine at Oxford<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: none; border-right: 1pt solid windowtext; border-top: 1pt solid windowtext; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><span style="font-size: 10pt;">&nbsp;</span></p></td></tr><tr><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><span style="color: #006600; font-size: 10pt;">Supportive evidence from well-conducted randomized controlled trials that are adequately powered, including:<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; text-indent: -0.25in;"><span style="color: #006600; font-family: Symbol; font-size: 10pt;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="color: #006600; font-size: 10pt;">Evidence from a well-conducted trial at one or more institutions<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; text-indent: -0.25in;"><span style="color: #006600; font-family: Symbol; font-size: 10pt;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="color: #006600; font-size: 10pt;">Evidence from a meta-analysis that incorporated quality ratings in the analysis<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; text-indent: -0.25in;"><span style="font-family: Symbol; font-size: 10pt;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="font-size: 10pt;">&nbsp;</span></p></td></tr><tr><td rowspan="2" style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><b><span style="color: #c00000; font-size: 10pt;">B<o:p></o:p></span></b></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><span style="color: #006600; font-size: 10pt;">Supportive evidence from&nbsp;<b><i>well-conducted cohort studies</i></b>, including:<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; text-indent: -0.25in;"><span style="color: #006600; font-family: Symbol; font-size: 10pt;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="color: #006600; font-size: 10pt;">Evidence from a well-conducted prospective cohort study or registry<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; text-indent: -0.25in;"><span style="color: #006600; font-family: Symbol; font-size: 10pt;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="color: #006600; font-size: 10pt;">Evidence from a well-conducted meta-analysis of cohort studies<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;"></td></tr><tr><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><span style="color: #006600; font-size: 10pt;">Supportive evidence from a&nbsp;<b><i>well-conducted case-control study</i></b><o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><span style="font-size: 10pt;">&nbsp;</span></p></td></tr><tr><td rowspan="2" style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><b><span style="color: #c00000; font-size: 10pt;">C<o:p></o:p></span></b></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><span style="color: #006600; font-size: 10pt;">Supportive evidence from&nbsp;<b><i>poorly controlled or uncontrolled studies</i></b>, including:<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; text-indent: -0.25in;"><span style="color: #006600; font-family: Symbol; font-size: 10pt;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="color: #006600; font-size: 10pt;">Evidence from randomized clinical trials with one or more major or three or more minor methodological flaws that could invalidate the results<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; text-indent: -0.25in;"><span style="color: #006600; font-family: Symbol; font-size: 10pt;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="color: #006600; font-size: 10pt;">Evidence from observational studies with high potential for bias (such as case series with comparison to historical controls)<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 11.25pt 0in 11.25pt 66.6pt; text-indent: -0.25in;"><span style="color: #006600; font-family: Symbol; font-size: 10pt;"><img alt="*" height="11" src="PicExportError" width="11" /><span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="color: #006600; font-size: 10pt;">Evidence from case series or case reports<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;"></td></tr><tr><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><span style="color: #006600; font-size: 10pt;">Conflicting evidence with the weight of evidence supporting the recommendation<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><span style="font-size: 10pt;">&nbsp;</span></p></td></tr><tr><td style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><b><span style="color: #c00000; font-size: 10pt;">E<o:p></o:p></span></b></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><b><i><span style="color: #006600; font-size: 10pt;">Expert consensus or clinical experience<o:p></o:p></span></i></b></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;"></td></tr></tbody></table><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319668">Grading of hypertensive retinopathy</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">&nbsp;</span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">Keith and Wegner (1939)</span></b>&nbsp;have classified hypertensive retinopathy changes into following four grades:</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span lang="EN">Patients were grouped according to their ophthalmoscopic findings. As such, this was the first system to correlate retinal findings with the hypertensive disease state.<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Grade I:</b>&nbsp;It consists of mild generalized arteriolar attenuation, particularly of small branches, with broadening of the arteriolar light reflex and vein concealment.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Grade II:</b>&nbsp;It comprises marked generalized narrowing and focal attenuation of arterioles associated with deflection of veins at arteriovenous crossings (Salus’ sign).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Grade III:</b>&nbsp;This consists of Grade II changes plus copper-wiring of arterioles, banking of veins distal to arteriovenous crossings (Bonnet sign), tapering of veins on either side of the crossings (Gunn sign) and right-angle deflection of veins (Salu’s sign). Flame-shaped haemorrhages, cotton-wool spots and hard exudates are also present.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Grade IV:</b>&nbsp;This consists of all changes of Grade III plus silver-wiring of arterioles and papilloedema.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-size: 10pt; line-height: 15.3333px;">One of the major limitations of this classification system is the difficulty in distinguishing early hypertensive retinopathy grades (e.g., grade 1 from grade 2); thus, a modified classification has been recently proposed.<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span lang="EN">&nbsp;</span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span lang="EN" style="color: #e36c0a;">Scheie classification (1953)<o:p></o:p></span></b></p><p style="font-family: &quot;Times New Roman&quot;, serif; margin-left: 0in; margin-right: 0in;"><span lang="EN" style="font-family: Calibri, sans-serif;">Staging under this system is as follows:<o:p></o:p></span></p><ul style="margin-bottom: 0in;" type="disc"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Stage 0 - Diagnosis of hypertension but no visible retinal abnormalities<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Stage 1 - Diffuse arteriolar narrowing; no focal constriction<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Stage 2 - More pronounced arteriolar narrowing with focal constriction<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Stage 3 - Focal and diffuse narrowing, with retinal hemorrhage<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Stage 4 - Retinal edema, hard exudates, optic disc edema<o:p></o:p></span></li></ul><p style="font-family: &quot;Times New Roman&quot;, serif; margin-left: 0in; margin-right: 0in;"><span lang="EN" style="font-family: Calibri, sans-serif;">The Scheie classification also grades the light reflex changes from arteriolosclerotic changes, as follows:<o:p></o:p></span></p><ul style="margin-bottom: 0in;" type="disc"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Grade 0 - Normal<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Grade 1 - Broadening of light reflex with minimal arteriolovenous compression<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Grade 2 - Light reflex changes and crossing changes more prominent<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Grade 3 - Copper-wire appearance; more prominent arteriolovenous compression<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Grade 4 - Silver-wire appearance; severe arteriolovenous crossing changes<o:p></o:p></span></li><li class="MsoNormal" style="color: #990000; font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 10pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Scheie Classification<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">&nbsp;</span></li></ul><table border="1" cellpadding="0" class="MsoNormalTable"><thead><tr><td style="padding: 1.5pt;" valign="bottom"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><b><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Group</span></b><span style="font-family: Verdana, sans-serif; font-size: 10pt;"><o:p></o:p></span></p></td><td style="padding: 1.5pt;" valign="bottom"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><b><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Hypertension</span></b><span style="font-family: Verdana, sans-serif; font-size: 10pt;"><o:p></o:p></span></p></td><td style="padding: 1.5pt;" valign="bottom"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><b><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Arteriolar sclerosis</span></b><span style="font-family: Verdana, sans-serif; font-size: 10pt;"><o:p></o:p></span></p></td></tr></thead><tbody><tr><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">0<o:p></o:p></span></p></td><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">No changes<o:p></o:p></span></p></td><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Normal<o:p></o:p></span></p></td></tr><tr><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">1<o:p></o:p></span></p></td><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Barely detectable arteriolar narrowing<o:p></o:p></span></p></td><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Barely detectable light reflex changes<o:p></o:p></span></p></td></tr><tr><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">2<o:p></o:p></span></p></td><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Obvious arteriolar narrowing with focal irregularities<o:p></o:p></span></p></td><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Obvious increased light reflex changes<o:p></o:p></span></p></td></tr><tr><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">3<o:p></o:p></span></p></td><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Grade 2 plus retinal hemorrhages or exudates<o:p></o:p></span></p></td><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Copper wire arterioles<o:p></o:p></span></p></td></tr><tr><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">4<o:p></o:p></span></p></td><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Grade 3 plus papilledema<o:p></o:p></span></p></td><td style="padding: 1.5pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 12pt; margin: 0in 0in 0.0001pt;"><span style="font-family: Verdana, sans-serif; font-size: 10pt;">Silver wire arterioles<o:p></o:p></span></p></td></tr></tbody></table><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319669"><span lang="EN">Modified Scheie classification</span></a><span lang="EN"><o:p></o:p></span></h3><p style="font-family: &quot;Times New Roman&quot;, serif; margin-left: 0in; margin-right: 0in;"><span lang="EN" style="font-family: Calibri, sans-serif;">Staging is as follows:<o:p></o:p></span></p><ul style="margin-bottom: 0in;" type="disc"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Grade 0 - No changes<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Grade 1 - Barely detectable arterial narrowing<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Grade 2 - Obvious arterial narrowing with focal irregularities<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Grade 3 - Grade 2 plus retinal hemorrhages and/or exudates<o:p></o:p></span></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 10pt;"><span lang="EN">Grade 4 - Grade 3 plus disc swelling<o:p></o:p></span></li></ul><p class="MsoNormal" style="background: white; font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 5pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span lang="EN" style="color: #e36c0a;">Classification of hypertensive retinopathy by Wong and Mitchell</span></b><b><span style="color: #e36c0a;"><o:p></o:p></span></b></p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none;"><tbody><tr><td style="border: 1pt solid windowtext; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><b><i><span style="color: red; font-family: Arial, sans-serif;">Grades</span></i></b><b><i><span style="color: red; font-size: 12pt;"><o:p></o:p></span></i></b></p></td><td style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: none; border-right: 1pt solid windowtext; border-top: 1pt solid windowtext; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><b><i><span style="color: red; font-size: 12pt;">&nbsp;</span></i></b></p></td><td style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: none; border-right: 1pt solid windowtext; border-top: 1pt solid windowtext; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><b><i><span style="color: red; font-family: Arial, sans-serif;">Description</span></i></b><b><i><span style="color: red; font-size: 12pt;"><o:p></o:p></span></i></b></p></td><td style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: none; border-right: 1pt solid windowtext; border-top: 1pt solid windowtext; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><b><i><span style="color: red; font-size: 12pt;">&nbsp;</span></i></b></p></td><td style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: none; border-right: 1pt solid windowtext; border-top: 1pt solid windowtext; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><b><i><span style="color: red; font-family: Arial, sans-serif;">Systemic associations</span></i></b><b><i><span style="color: red; font-size: 12pt;"><o:p></o:p></span></i></b></p></td></tr><tr><td style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><span style="color: red; font-size: 12pt;">No retinopathy<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><span style="color: #0070c0; font-size: 12pt;">No detectable retinal signs<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><span style="color: #c00000; font-size: 12pt;">None<o:p></o:p></span></p></td></tr><tr><td style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><span style="color: red; font-size: 12pt;">Mild retinopathy (retinal arteriolar signs only)<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><span style="color: #0070c0; font-size: 12pt;">One or more of the following arteriolar signs: • Generalised arteriolar narrowing • Focal arteriolar narrowing • Arteriovenous nicking • Arteriolar wall opacity (silver wiring)<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><span style="color: #c00000; font-size: 12pt;">Modest* association with risk of clinical stroke, subclinical stroke, coronary heart disease, and mortality.<o:p></o:p></span></p></td></tr><tr><td style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><span style="color: red; font-size: 12pt;">Moderate retinopathy<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><span style="color: #0070c0; font-size: 12pt;">One or more of the following retinal signs: • Haemorrhage (blot, dot, or flame shaped) • Microaneurysm • Cottonwool spot • Hard exudates<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><span style="color: #c00000; font-size: 12pt;">Strong† association with risk of clinical stroke, subclinical stroke, cognitive decline, and cardiovascular mortality<o:p></o:p></span></p></td></tr><tr><td style="border-bottom: 1pt solid windowtext; border-image: initial; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><span style="color: red; font-size: 12pt;">Malignant retinopathy<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><span style="color: #0070c0; font-size: 12pt;">Moderate retinopathy plus optic disc swelling‡<o:p></o:p></span></p></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"></td><td style="border-bottom: 1pt solid windowtext; border-left: none; border-right: 1pt solid windowtext; border-top: none; padding: 0.75pt;" valign="top"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8pt; margin: 0in 0in 0.0001pt;"><span style="color: #c00000; font-size: 12pt;">Strong association with mortality<o:p></o:p></span></p></td></tr></tbody></table><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319670">Grading of DR:</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b0f0;">1. Mild NPDR:</span></b>&nbsp;At least one microaneurysm or intraretinal hemorrhage.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Hard/soft exudates may or may not be present.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b0f0;">2. Moderate NPDR:</span></b>&nbsp;Moderate microaneurysms/intraretinal hemorrhage.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Early mild IRMA.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Hard/soft exudates may or may not present.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b0f0;">3. Severe NPDR.</span></b>&nbsp;Any one of the following (4-2-1 Rule):</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Four quadrants of severe microaneurysms/ intraretinal hemorrhages.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Two quadrants of venous beading.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">One quadrant of IRMA changes.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b0f0;">4. Very severe NPDR</span></b>. Any two of the following (4-2-1 Rule):</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Four quadrants of severe microaneurysms/ intraretinal hemorrhages.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Two quadrants of venous beading.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">One quadrant of IRMA changes.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b0f0;">Proliferative diabetic retinopathy (PDR)<o:p></o:p></span></b></p><ol start="1" style="margin-bottom: 0in; margin-top: 0in;" type="1"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">PDR without HRCs (Early PDR) and</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">PDR with HRCs (Advanced PDR). High risk characteristics (HRC) of PDR are as follows (Fig. 11.14F):</li></ol><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.75in; text-indent: -0.25in;">1.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>NVD 1/4 to 1/3 of disc area with or without vitreous haemorrhage (VH) or pre-retinal haemorrhage (PRH)</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.75in; text-indent: -0.25in;">2.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>NVD &lt; 1/4 disc area with VH or PRH</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.75in; text-indent: -0.25in;">3.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>NVE &gt; 1/2 disc area with VH or PRH</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b0f0;">clinically significant macular edema (CSME)</span></b>&nbsp;if one of the following three criteria are present on slit-lamp examination with 90D lens:</p><ol start="1" style="margin-bottom: 0in; margin-top: 0in;" type="1"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Thickening of the retina at or within 500 micron of the centre of the fovea.</li><li class="MsoNormal" style="color: red; font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="color: windowtext;">Hard exudate at or within 500 micron of the centre of fovea associated&nbsp;</span><b><i>with adjacent retinal thickening</i></b><span style="color: windowtext;">&nbsp;</span><b><i>and not residual hard exudates remaining after the disappearance of retinal thickening<o:p></o:p></i></b></li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Development of a zone of retinal thickening one disc diameter or larger in size, at least a part of which is within one disc diameter of the foveal centre.</li></ol><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319671">DME</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in;">Based on OCT DME can be classified into different pattern such as</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.75in; text-indent: -0.25in;">1.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>cystoid macular edema,</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.75in; text-indent: -0.25in;">2.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>spongy swelling of the retina,</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.75in; text-indent: -0.25in;">3.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>hard exudates,</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.75in; text-indent: -0.25in;">4.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>serous detachment,</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.75in; text-indent: -0.25in;">5.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>macular traction,</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.75in; text-indent: -0.25in;">6.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>taut posterior hyaloid membrane.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319672">Grading of trachoma</a><span class="section-title-3"><o:p></o:p></span></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">McCallan's classification<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">McCallan in 1908, divided the clinical course of the trachoma into following four stages:</p><ul style="margin-bottom: 0in; margin-top: 0in;" type="disc"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage I (Incipient trachoma or stage of infiltration). It is characterized by hyperaemia of palpebral conjunctiva and immature follicles.</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage II (Established trachoma or stage of florid infiltration). It is characterized by appearance of mature follicles, papillae and progressive corneal pannus.</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage III (Cicatrising trachoma or stage of scarring). It includes obvious scarring of palpebral conjunctiva.</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage IV (Healed trachoma or stage of sequelae). The disease is quite and cured but sequelae due to cicatrisation give rise to symptoms.</li></ul><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">WHO<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">TF = trachomatous inflammation (follicular): five or more follicles (&gt;0.5&nbsp;mm) on the superior tarsus</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">TI = trachomatous inflammation (intense):diffuse involvement of the tarsal conjunctiva, obscuring 50% or more of the normal deep tarsal vessels; papillae are present</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">TS = trachomatous conjunctival scarring: easily visible fibrous white tarsal bands</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">TT = trachomatous trichiasis: at least one lash touching the globe</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">CO = corneal opacity sufficient to blur details of at least part of the pupillary margin</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319673">WHO grading of Xerophthalmia</a><span class="section-title-3"><o:p></o:p></span></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">XN = night blindness</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">X1 = conjunctival xerosis (X1A) with Bitot spot (X1B)</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">X2 = corneal xerosis</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">X3 = corneal ulceration, less than one-third (X3A); more than one-third (X3B)</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">XS = corneal scar</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">XF = xerophthalmic fundus</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319674">Grading of nucleus hardness on slit-lamp biomicroscopy</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade I: Soft, White or greenish yellow</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade II: Soft-medium, Yellowish</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade III: Medium-hard, Amber</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade IV: Hard, Brownish</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade V: Ultrahard, Blackish (rock-hard)</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319675"></a><a name="4-u1.0-B978-0-7020-4093-1..00021-5--s024"></a><a name="4-u1.0-B978-0-7020-4093-1..00021-5--st02"></a><span class="section-title-3">Grading of severity of Chemical Injury</span><span class="section-title-3"><o:p></o:p></span></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grading is performed on the basis of corneal clarity and severity of limbal ischaemia (Roper-Hall system); the latter is assessed by observing the patency of the deep and superficial vessels at the limbus (Fig. 21.29A).<a name="4-u1.0-B978-0-7020-4093-1..00021-5--ulis"></a></p><table border="0" cellpadding="0" class="MsoNormalTable"><tbody><tr><td style="padding: 0.75pt; width: 1.5pt;" width="2"></td><td style="padding: 0.75pt; width: 39px;" valign="top" width="4%"></td><td style="padding: 0.75pt;"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><a name="4-u1.0-B978-0-7020-4093-1..00021-5--u083"></a>Grade 1 is characterized by clear cornea (epithelial damage only) and no limbal ischaemia (excellent prognosis).</p></td></tr><tr><td style="padding: 0.75pt; width: 1.5pt;" width="2"></td><td style="padding: 0.75pt; width: 39px;" valign="top" width="4%"></td><td style="padding: 0.75pt;"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><a name="4-u1.0-B978-0-7020-4093-1..00021-5--u084">Grade 2 shows hazy cornea but with visible iris details (Fig. 21.29B) and less than one-third of the limbus being ischaemic (good prognosis).</a></p></td></tr><tr><td style="padding: 0.75pt; width: 1.5pt;" width="2"></td><td style="padding: 0.75pt; width: 39px;" valign="top" width="4%"></td><td style="padding: 0.75pt;"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade 3 manifests total loss of corneal epithelium, stromal haze obscuring iris details (Fig. 21.29C) and between one-third and half limbal ischaemia (guarded prognosis).</p></td></tr><tr><td style="padding: 0.75pt; width: 1.5pt;" width="2"></td><td style="padding: 0.75pt; width: 39px;" valign="top" width="4%"></td><td style="padding: 0.75pt;"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><a name="4-u1.0-B978-0-7020-4093-1..00021-5--u085"></a>Grade 4 shows opaque cornea (Fig. 21.29D) and more than half limbal ischaemia (very poor prognosis).</p></td></tr></tbody></table><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319676">PVR Gradings: (Retina Society Terminology Committee, 1983)</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Grade A:</b>&nbsp;vitreous changes (RPE clumps, protein flare)</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Grade B:&nbsp;</b>surface wrinkling, rolled edge of tears, vascular tortuosity</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Grade C:</b>&nbsp;full thickness retinal folds</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt; text-indent: 0.5in;"><b><i><span style="color: #00b050;">Ryan:<o:p></o:p></span></i></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt; text-indent: 0.5in;">C1,C2,C3: 1,2,3 quadrent respectively</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><i><span style="color: #00b050;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jakobiec:<o:p></o:p></span></i></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;">C1: Posterior star fold</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;">C2: Posterior confluent irregular folds</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;">C3: Posterior subretinal ‘napkin irregular elevation of retina</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;">C4: Anterior irregular folds</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;">C5: Anterior smooth circumferential retinal fold in coronal plane</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;">C6: Anterior circumferential fold of retina at insertion of posterior hyaloid</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Grade D:</b>&nbsp;Fixed Retinal Fold in four quadrents</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D1: Wide Funnel Shape</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D2: Narrow Funnel Shape</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D3: Closed Funnel Shape</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><i><span style="color: #c00000;">This classification system has following disadvantages:<o:p></o:p></span></i></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Symbol;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>There was no clinical correlation between the most severe form (grade D) and visual prognosis.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Symbol;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>There was limited quantification of extent of disease.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Symbol;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>This system did not include PVR anterior to the equator.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #7030a0;">The new classification system consists of the following modified PVR grades:<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">A – Pigment clumps in the vitreous cavity, vitreous haze</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">B – Retinal wrinkling breaks with rolled edges, retinal rigidity, vascular tortuousity, and decreased vitreous mobility</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">C – Full thickness fixed folds (subdivided into anterior and posterior forms)</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Extent of involvement expressed in clock hours (subdivided into contraction types):</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>CP1-12<o:p></o:p></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>CA1-12<o:p></o:p></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>&nbsp;</b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>1. Focal posterior</b>&nbsp;– single or multiple isolated folds posterior to vitreous base.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>2. Diffuse posterior</b>&nbsp;– confluence of focal epicenters posterior to vitreous base.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>3. Subretinal proliferations</b>&nbsp;–bands of moth eaten sheets; extent quantified if retina is elevated.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>4. Circumferential traction</b>&nbsp;along the posterior edge of vitreous base with central displacement of retina and radial folds posteriorly.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>5. Anterior traction</b>&nbsp;– vitreous base displaced to pars plicata, iris or pupillary margin.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Shortcomings of these classifications are that they&nbsp;<b><i><span style="color: #c00000;">do not take into account important features that influence the prognosis.<o:p></o:p></span></i></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">1. Number, location and size of retinal breaks</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">2. Number and type of previous operation</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">3. Time course and biological activity of the proliferative process.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319677"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Stages of development of PVR (</a><span style="color: red;">CPEC</span>)</h3><ol start="1" style="margin-bottom: 0in; margin-top: 0in;" type="1"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Cellular activation</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Proliferation</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Extracellular matrix elaboration and remodeling</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Contraction</li></ol><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319678">Eales’ Disease (</a><span style="color: red;">PINK</span>)</h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #7030a0;">Charmis Classification:<o:p></o:p></span></b></p><ol start="1" style="margin-bottom: 0in; margin-top: 0in;" type="1"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage of Active Phlebitis</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">The Stage of Persistent Ischaemia</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">The Stage of Vascular Proliferation</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">The Stage of Complications</li></ol><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #7030a0;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #7030a0;">Eales’ disease staging system (Saxena S)<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">This classification system is based on both fundoscopic and fluorescein angiographic variables that</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">have been shown to be prognostic of visual outcome.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>A. Eales’ disease<o:p></o:p></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage 1a Periphlebitis of small caliber vessels with superficial retinal hemorrhages.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage 1b Periphlebitis of large caliber vessels with superficial retinal hemorrhages.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage 2a Peripheral capillary nonperfusion.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage 2b Neovascularization elsewhere /Neovascularisation of the disc.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage 3a Fibrovascular proliferation.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage 3b Vitreous hemorrhage.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage 4a Traction / combined rhegmatogenous detachment.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage 4b Rubeosis iridis, neovascular glaucoma, complicated cataract, and optic atrophy.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>B. Central Eales’ disease<o:p></o:p></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt; text-indent: 0.25in;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt; text-indent: 0.25in;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319679">Macular Hole</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">0: premacular hole</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">1: impending macular holes</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">small yellow spot (stage lA) or yellow ring (stage IB) in the center of the fovea.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">2: A stage 2 macular hole represents the progression of a foveal pseudocyst to a full thickness dehiscence, as a tractional break develops in the “roof ” (inner layer) of the pseudocyst (&lt;400um)</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">3: A stage 3 macular hole is a fully developed hole (&gt;400 um diameter),</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">4: A stage 4 macular hole is a fully developed hole with a complete posterior vitreous detachment signified by a Weiss ring</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319680">Gass classification of ERM</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">● Grade 0 – cellophane maculopathy</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">So called due to cellophane-like sheen seen on ophthalmoscopic examination</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">No associated visual distortion</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">● Grade 1 – crinkled cellophane maculopathy</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Membrane causes an irregular wrinkling of inner retinal surface (Figure 5)</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Contraction of the membrane causes formation of retinal folds</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Fine superficial folds extend out from the margins of the membrane</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">If wrinkling is severe enough, paramacular vessels may be pulled towards the fovea in a corkscrew</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">formation. This is seen well on FFA</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Normally cystoid macular oedema, retinal haemorrhage, exudates and retinal pigment epithelial</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">disturbances are absent</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Patient will report visual disturbance and VAs of 6/12 or worse are common</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">● Grade 2 – macular pucker</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Membrane will be thick and opaque, especially for those membranes which develop following</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">retinal detachment surgery</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Full thickness puckering of the macula may be present along with oedema, small hemorrhages,</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">cotton-wool spots and sometimes localised retinal detachment</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Vision will be severely debilitated with VAs often worse than 6/60</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319681">Classiﬁcation of the posterior vitreoretinal interface</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">0: No PVD</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">1: Incomplete perifoveal PVD in up to 3 quadrants</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">2: Incomplete perifoveal PVD in all 4 quadrants with residual attachment to the fovea and optic disc</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">3: Incomplete PVD over the posterior pole with residual attachment to the optic disc</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">4: Complete PVD identiﬁed biomicroscopically, but posterior hyaloid face not visible on OCT imaging</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319682">Stages of Age-Related Posterior Vitreous Detachment</a><o:p></o:p></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage 1: Perifoveal separation with vitreofoveal adhesion.<o:p></o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage 2: Complete vitreomacular separation.<o:p></o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage 3: Widespread vitreous separation except at the optic disk margin.<o:p></o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage 4: Complete, clinically recognizable PVD.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319683">Grading of angle width</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">Shaffer system<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">The Shaffer system records the angle in degrees between two imaginary lines tangential to the inner surface of the trabeculum and the anterior surface of the iris about one-third of the distance from its periphery. In practice, the angle is graded by many according to the visibility of various structures. The system assigns a numerical grade to each quadrant of the angle as below (Fig. 10.17); it should be borne in mind that most angles are narrowest superiorly.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Wingdings;">ü<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;</span></span>Grade 4 (35–45°) is the widest angle, characteristic of myopia and aphakia, in which the ciliary body can be visualized with ease.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Wingdings;">ü<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;</span></span>Grade 3 (25–35°) is an open angle in which at least the scleral spur can be identified.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Wingdings;">ü<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;</span></span>Grade 2 (20°) is a moderately narrow angle in which only the trabeculum can be identified.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Wingdings;">ü<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;</span></span>Grade 1 (10°) is a very narrow angle in which only Schwalbe line, and perhaps also the top of the trabeculum, can be identified.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Wingdings;">ü<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;</span></span>Slit angle is one in which there is no obvious iridocorneal contact but no angle structures can be identified.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Wingdings;">ü<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;</span></span>Grade 0 (0°) is a closed angle due to iridocorneal contact and is recognized by the inability to identify the apex of the corneal wedge. Indentation gonioscopy will distinguish ‘appositional’ from ‘synechial’ angle closure (see Fig. 10.20).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">R P C classification<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in;">Grade 0&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Closed</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in;">Grade 1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dipping of light</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in;">Grade 2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Schwalbe’s line visible</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in;">Grade 3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;anterior trabecular meshwork</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in;">Grade 4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;posterior T M scleral spur</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in;">Grade 5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ciliary body band visible&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in;">Grade 6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;root of iris visible</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b050;">Grade the amount of TM pigment&nbsp;</span></b><b><span style="color: #00b050; font-family: Times-Roman, serif;">:<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Times-Roman, serif;">Scheie suggested a system of grading<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Times-Roman, serif;">0 none, +1 trace, +2 mild, +3 moderate, +4 severe<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Times-Roman, serif;">(+3 corresponds to iris pigmentation)<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319684">Grading anterior chamber cells (SUN-Standardization of uveitis nomenclature)</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">&nbsp;<b><i>Other grading systems are&nbsp;<span style="color: #548dd4;">Schlaegel’s &amp; Hogan’s.<o:p></o:p></span></i></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">&lt;1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-0</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">1–5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-±</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">6–15&nbsp;&nbsp;-+1</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">16–25 -+2</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">26–50 -+3</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">&gt;50&nbsp;&nbsp;&nbsp;-+4</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319685">Grading of aqueous flare (SUN Working Group Grading Scheme)</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Nil&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-0</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Just detectable&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-+1</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Moderate (iris and lens details clear)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;+2</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Marked (iris and lens details hazy)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;+3</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Intense (fibrinous exudate)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;+4</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319686">Grading of vitreous haze</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h5 style="font-family: Calibri, sans-serif; font-size: 13pt; font-style: italic; line-height: 19.9333px; margin: 12pt 0in 3pt;">According to EVS:</h5><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Good view of nerve fibre layer (NFL)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Clear disc and vessels but hazy NFL&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;+1</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Disc and vessels hazy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;+2</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Only disc visible&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;+3</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Disc not visible&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;+4</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319687">The grading of arteriolosclerosis:</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade 1: subtle broadening of the arteriolar light reflex, mild generalized arteriolar attenuation, particularly of small branches, and vein concealment.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade 2: obvious broadening of the arteriolar light reflex and deflection of veins at arteriovenous crossings (Salus sign).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade 3:</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 1in; text-indent: -0.25in;"><span style="font-family: Wingdings;">Ø<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;</span></span>‘Copper-wiring’ of arterioles (Fig. 13.51C).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 1in; text-indent: -0.25in;"><span style="font-family: Wingdings;">Ø<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;</span></span>Banking of veins distal to arteriovenous crossings (Bonnet sign).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 1in; text-indent: -0.25in;"><span style="font-family: Wingdings;">Ø<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;</span></span>Tapering of veins on both sides of the crossings (Gunn sign) and right-angled deflection of veins.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade 4: ‘Silver-wiring’ of arterioles associated with grade 3 changes.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319688">Staging of ROP</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">The following five stages are used to describe the abnormal vascular response at the junction of immature avascular peripheral retina and vascularized posterior retina. Because more than one ROP stage may be present in the same eye, staging for the eye as a whole is determined by the most severe manifestation.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Symbol;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Stage 1 (demarcation line) is a thin, flat, tortuous, grey-white line running roughly parallel with the ora serrata. It is more prominent in the temporal periphery. There is abnormal branching or ‘arcading’ of vessels leading up to the line (Fig. 13.60A).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Symbol;">·</span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Symbol;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Stage 2 (ridge) arises in the region of the demarcation line, has height and width, and extends above the plane of the retina. Blood vessels enter the ridge and small isolated neovascular tufts (‘popcorn’) may be seen posterior to it (Fig. 13.60B).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Symbol;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Stage 3 (extraretinal fibrovascular proliferation) extends from the ridge into the vitreous (Fig. 13.60C). It is continuous with the posterior aspect of the ridge, causing a ragged appearance as the proliferation becomes more extensive. The severity of stage 3 can be subdivided into mild, moderate and severe depending on the extent of extraretinal fibrous tissue infiltrating the vitreous. The highest incidence of this stage is around the post-conceptual age of 35 weeks.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Symbol;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Stage 4 (partial retinal detachment) is divided into extrafoveal (stage 4A – Fig. 13.60D) and foveal (Stage 4B). The detachment is generally concave and circumferentially orientated. In progressive cases the fibrous tissue continues to contract and the detachment increases in height and extends anteriorly and posteriorly.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.25in; text-indent: -0.25in;"><span style="font-family: Symbol;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Stage 5 is a total retinal detachment.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319689"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Grading of North Carolina macular dystrophy</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in; text-indent: -0.25in;">1.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>Grade 1 is characterized by yellow-white, drusen-like peripheral (Fig. 15.33A) and macular deposits which develop during the 1st decade and may remain asymptomatic throughout life.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in; text-indent: -0.25in;">2.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>Grade 2 is characterized by deep, confluent macular deposits (Fig. 15.33B). The long-term visual prognosis is guarded because some patients develop neovascular maculopathy (Fig. 15.33C) and subretinal scarring.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in; text-indent: -0.25in;">3.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>Grade 3 is characterized by coloboma-like atrophic macular lesions (Fig. 15.33D) associated with variable impairment of visual acuity.</p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319690"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Grading of binocular vision</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in; text-indent: -0.25in;">1.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>simultaneous perception, SP</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in; text-indent: -0.25in;">2.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>fusion</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in; text-indent: -0.25in;">3.<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>stereopsis</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319691"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>NVG</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">(a) rubeosis iridis, (b) secondary open-angle glaucoma and (c) secondary synechial angle-closure glaucoma.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319692"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Stages of Proliferative retinopathy</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">&nbsp;</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Stage 1</b>&nbsp;shows peripheral arteriolar occlusion and ischaemia.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Stage 2</b>&nbsp;is characterized by peripheral arteriovenous anastomoses of dilated pre-existing capillary channels (Fig. 13.55A).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Stage 3<o:p></o:p></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Sprouting of new vessels from the anastomoses; these have a ‘sea-fan’ configuration and are usually fed by a single arteriole and drained by a single vein (Fig. 13.55B and see Fig. 13.56A).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">About 30–40% of sea-fans involute spontaneously as a result of auto-infarction and appear as greyish fibrovascular lesions (Fig. 13.55C). Involution most frequently occurs about 2 years after the development of retinopathy.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Stage 4.</b>&nbsp;The neovascular tufts may continue to proliferate and bleed into the vitreous (Fig. 13.55D).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b>Stage 5</b>&nbsp;is characterized by extensive fibrovascular proliferation (Fig. 13.55E) and retinal detachment</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319693"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>ocular GVHD</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Jab et al. described four stages of ocular GVHD:</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage I – hyperemia; Stage II – hyperemia with serosanguinous chemosis; Stage III – pseudomembranous conjunctivitis; and Stage IV – pseudomembranous conjunctivitis with corneal epithelial sloughing.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319694"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>OCP</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">The disease progression of OCP has classically been documented into one of four stages.[7] Stage I denotes chronic conjunctivitis with subepithelial fibrosis. Stage II refers to inferior fornix foreshortening. Stage III describes symblepharon formation typically involving the inferior fornix. Finally, stage IV is the end-stage characterized by ankyloblepharon formation and corneal scarring</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319695"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>neurotrophic keratitis</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Mackie[45] characterized three stages of neurotrophic keratitis. Stage one includes an often subtle irregular corneal surface, which later develops into an easily recognized punctate keratitis. Stage two is characterized by a frank epithelial defect, which typically is associated with mild anterior stromal inflammation ( Fig. 4-17-9 ). Folds in Descemet’s membrane often develop. The epithelium at the edges of the defect tends to be characteristically “heaped up” with grayish, swollen epithelium. The ulcer typically found in the lower, exposed, paracentral cornea and is generally oval in shape ( Fig. 4-17-10 ). Stage three involves stromal melting and occasionally perforation. Other characteristic symptoms include red eye, mild foreign body sensation, blurred vision, and lid edema. The severity of the anesthesia generally corresponds to the severity of the keratitis.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319696"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>spheroidal degeneration</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Three stages of the primary form have been described:</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade I – fine shiny droplets are present only peripherally without symptoms.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade II – the central cornea is involved and vision may be as low as 20/100 (6/30).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade III – there are large corneal nodules and vision is no better than 20/200 (6/60).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319697"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>PSR</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Because PSR can lead to severe vision loss, it was classified into five stages by Goldberg. [2] [12] [15] This progression of retinopathy typically occurs in the third or fourth decade of life but has been noted as early as the second decade. The five stages are as follows:</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">1.&nbsp;&nbsp;&nbsp;Peripheral arteriolar occlusions.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">2.&nbsp;&nbsp;&nbsp;Arteriolar-venular anastomoses.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">3.&nbsp;&nbsp;&nbsp;Neovascular proliferation.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">4.&nbsp;&nbsp;&nbsp;Vitreous hemorrhage.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">5.&nbsp;&nbsp;&nbsp;Retinal detachment.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319698"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Lyme disease</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">is characterized by three main stages:</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Primary, or initial, phase with rash noted at the site of the inoculum (erythema chronicum migrans). Associated flu-like symptoms can be noted.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Secondary or dissemination phase with systemic signs and symptoms including dermatologic, neurologic, and cardiac manifestations.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Tertiary or late phase with associated arthritis, meningoencephalitis, polyneuropathies involving both cranial and peripheral nerves, and carditis.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319699"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Sarcoidosis</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage I consists of bilateral hilar adenopathy alone.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage II adds parenchymal involvement.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">In stage III, parenchymal disease predominates without prominent hilar involvement.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Stage IV is advanced disease characterized by pulmonary fibrosis.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319700"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>RHABDOMYOSARCOMA</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">There are four stages:</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">I. Localized tumor, completely resected</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">II. Regional spread, ± positive nodes, grossly resected</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">III. Gross residual tumor remaining after incomplete resection</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">IV. Distant metastases</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319701"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>OSD</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Van Bijsterveld created a grading scale for rose bengal dye that divides the ocular surface into three zones: nasal bulbar conjunctiva, cornea, and temporal bulbar conjunctiva, each graded 0–3 (0, none; 3, confluent staining).[36] Lemp and the National Eye Institute/Industry Workshop group[15] suggest that the conjunctiva be divided into six areas and graded in a similar manner ( Fig. 4-23-4 ). Alternatively, lissamine green stains for cell death or degeneration, as well as cell-to-cell junction disruption, but does not irritate the eye.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319702"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>RAPD</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade I: weak initial constriction followed by greater redilation;</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade II: a slight “stall” in movement, followed by a definite dilation;</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade III: immediate pupillary dilation [i.e., pupillary escape];</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade IV: pupillary dilation during prolonged illumination of the contralateral eye for 6 seconds, followed by constriction;</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade V: immediate pupillary dilation and no signs of constriction), these systems are subject to inter-observer errors and are affected by pupillary size; e.g., the small pupil may not show a detectable initial constriction.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">The amount of pupillomotor input asymmetry (the RAPD) may be estimated roughly using the alternating light test (without any neutral density filters) and the subjective grades +1, +2, +3, or +4 for asymmetry of pupillary response.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">This subjective grading also may be categorized according to the amount of “pupil escape,” or dilatation of the pupils, as the light is alternated between the eyes.[13] However, most subjective grading of RAPDs has serious limitations, such as some large-scale errors that arise from age variations in pupil size and pupil mobility. For example, a patient who has small pupils and small pupillary contractions to light may have a large RAPD, but this may appear deceptively small on the basis of small differences in pupil excursion observed as the light is alternated between the two eyes. However, the amount of neutral density filter needed to dim the better eye until the small contractions are equal represents substantial input damage. To estimate the size of RAPDs without using filters is very much like the estimation of an ocular deviation “by Hirschberg” without a prism cover test. More accurate quantification of RAPDs is accomplished by determination of the log unit difference needed to “balance” the pupil reaction between the two eyes. [4] [5] Photographic neutral density filters (49mm, screw mount, 0.3 log, 0.6 log, and 0.9 log) often are available through local photography stores.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319703"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>VAN HERRICK GRADING OF THE PERIPHERAL ANTERIOR CHAMBER DEPTH</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">4: &gt; 1 PCT</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">3: ¼ to ½ PCT</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">2: ¼ PCT</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">1: &lt; ¼ PCT</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Slit: Dangerously narrow</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319704"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>limbal chamber depth method</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">The limbal chamber depth method of grading the peripheral anterior chamber is a recent modification of the van Herick test.[37] Instead of the four grades used in the van Herick method, it has seven grades that are expressed as a percentage fraction of the thickness of the adjacent cornea: 0%, 5%, 15%, 25%, 40%, 75%, and 100%. The limbal chamber depth method has been demonstrated to perform better in the detection of established PACG and is now widely used in epidemiologic research.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319705"><span style="font-family: Symbol; font-weight: normal;">·<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>GRADING OF HYPERDEVIATION</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Trace: 5</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">1+: 10</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">2+: 20</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">3+: 30</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">4+: 45</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319706">BEST’s Disease</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Best's disease has been described as going through four phases based on fundus examination.</p><ol start="1" style="margin-bottom: 0in; margin-top: 0in;" type="1"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">The first, the&nbsp;<b>previtelliform</b>&nbsp;stage, is characterized by a normal fundus appearance.</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">The second stage, the&nbsp;<b>vitelliform</b>&nbsp;stage, usually occurs in early childhood and is characterized by a well-circumscribed 0.5-2-disk-diameter yellow lesion that looks like the yolk of an egg and appears to be located under the pigment epithelium. This is usually 0.5-2 optic disk diameters in size. Acuity is usually normal or slightly reduced. The lesion may be unilateral, and a yellowish change may be noted in the RPE throughout the fundus.</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">During the teenage years, or thereafter, the yellow lesion can break through the RPE into the subretinal space, and the yellow material can accumulate inferiorly in the macula in the subretinal space to form&nbsp;<b>pseudohypopyon</b>&nbsp;(the third stage).</li><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">A scrambled-egg appearance to the fundus then follows, with yellow deposits scattered&nbsp;<b>throughout the posterior pole</b>&nbsp;(the fourth stage).</li></ol><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319707">Lasers</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Lasers are divided into four “classes” based on their strength of output.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">&nbsp;</span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">Class 1</span></b>&nbsp;lasers, with a maximum output that is&nbsp;&nbsp;<b>&lt;0.4</b>&nbsp;mW, are considered the&nbsp;<b>safest</b>&nbsp;lasers and are believed incapable of causing damage even if viewed for long periods of time.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">Class 2</span></b>&nbsp;lasers have a maximum output&nbsp;<b>&lt;1 mW</b>. These are also felt to be&nbsp;<b>extremely unlikely</b>&nbsp;to result in ocular injury because of protective mechanisms conferred by the body’s natural blink response and aversion reflexes.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">Class 3A</span></b>&nbsp;lasers have a maximum output between&nbsp;<b>1 mW and 5 mW</b>, and although they cannot cause immediate eye injury, they can induce damage if stared directly at for&nbsp;<b>sustained periods</b>&nbsp;of time. Most laser pointers that are available in the United States are class 2 or class 3A lasers.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">Class 3B</span></b>&nbsp;lasers are much more powerful, with a maximum output between&nbsp;<b>5 mW and 500 mW</b>. These are believed to be capable of producing ocular damage&nbsp;<b>immediately</b>&nbsp;upon viewing. Although these lasers are illegal in some countries, they can be obtained quite easily via the Internet.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">Class 4</span></b>&nbsp;lasers are the most powerful lasers, boasting a maximal output&nbsp;<b>&gt;500 mW</b>. These are typically used in&nbsp;<b>military and occupational</b>&nbsp;settings, such as laser shows. They are capable of producing extensive ocular damage. Given the brevity of our patient’s exposure that still resulted in retinal injury, the laser involved was most likely a class 3B laser.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319708">VKH</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><ol start="1" style="margin-bottom: 0in; margin-top: 0in;" type="1"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">Prodromal phase</span></b>&nbsp;lasting a few days is characterized by neurological and auditory manifestations.</li></ol><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;">•&nbsp;&nbsp;&nbsp;Meningitis causing headache and neck stiffness.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;">•&nbsp;&nbsp;&nbsp;Encephalopathy is less frequent and may manifest with convulsions, paresis and cranial nerve palsies.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;">•&nbsp;&nbsp;&nbsp;Auditory features include tinnitus, vertigo and deafness.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><ol start="2" style="margin-bottom: 0in; margin-top: 0in;" type="1"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">Acute uveitic phase</span></b>&nbsp;follows soon thereafter and is characterized by bilateral granulomatous anterior or multifocal posterior uveitis and exudative retinal detachments.</li></ol><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;"><o:p>&nbsp;</o:p></p><ol start="3" style="margin-bottom: 0in; margin-top: 0in;" type="1"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">Convalescent phase</span></b>&nbsp;follows several weeks later and is characterized by:</li></ol><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;">•&nbsp;&nbsp;&nbsp;Localized alopecia, poliosis and vitiligo (Fig. 11.69).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;">•&nbsp;&nbsp;Focal depigmented fundus lesions (<b><span style="color: red;">sunset glow fundus</span></b>) and depigmented limbal lesions (<b><span style="color: red;">Sugiura sign</span></b>).</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in;"><o:p>&nbsp;</o:p></p><ol start="4" style="margin-bottom: 0in; margin-top: 0in;" type="1"><li class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a;">Chronic-recurrent phase</span></b>&nbsp;is characterized by smouldering anterior uveitis with exacerbations.</li></ol><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319709">Coat’s Disease:</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">stage 1, telangiectasia only;</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">stage 2, telangiectasia and exudation (2A, extrafoveal; 2B foveal);</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">stage 3, exudative retinal detachment (3A, subtotal; 3B total);</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">stage 4, total detachment with secondary glaucoma; and</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">stage 5, advanced end-stage disease.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319710">House-Brackmann Facial Nerve Grading System</a><o:p></o:p></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade Description Characteristics<o:p></o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Futura-Light, sans-serif;">I Normal Normal facial function<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Futura-Light, sans-serif;">II Mild dysfunction Very slight weakness found on close inspection; good forehead<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Futura-Light, sans-serif;">function; complete and quick eyelid closure<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Futura-Light, sans-serif;">III Moderate dysfunction Obvious but not disfiguring asymmetry; mild synkinesis; slight<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Futura-Light, sans-serif;">forehead movement; complete eyelid closure with effort<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Futura-Light, sans-serif;">IV Moderately severe dysfunction<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Futura-Light, sans-serif;">Disfiguring asymmetry; no forehead movement; incomplete<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Futura-Light, sans-serif;">eyelid closure<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Futura-Light, sans-serif;">V Severe dysfunction Barely perceptible facial movement; incomplete eyelid closure<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="font-family: Futura-Light, sans-serif;">VI Total paralysis No movement</span></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319711">FUCH’S DYSTROPHY</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">&nbsp;</span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">The&nbsp;<b>first stage</b>&nbsp;is asymptomatic, but guttae can be seen centrally on the posterior aspect of a thickened Descemet membrane. In the&nbsp;<b>second stage</b>, the patient may experience increased glare and a painless decrease in vision due to corneal edema. The cornea may begin to decompensate. In the&nbsp;<b>third stage</b>, vision deteriorates further owing to advanced corneal edema, and the patient may experience pain from the formation of epithelial and subepithelial bullae. The&nbsp;<b>fourth stage</b>&nbsp;is characterized by profound vision loss due to subepithelial scarring, which histologically appears as diffuse avascular subepithelial connective tissue.<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">&nbsp;</span></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319712">Corneal Ulcer</a><o:p></o:p></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">&nbsp;</span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">Stage 0: Stage of Infiltrate<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">Stage 1: Progressive Stage<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">Stage 2: Regressive Stage<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">Stage 3: Healing Stage<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">&nbsp;</span></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; width: 580px;"><tbody><tr style="height: 39.75pt;"><td style="border-color: rgb(255, 255, 204); border-image: initial; border-style: solid; border-width: 2.25pt 1pt 1pt; height: 39.75pt; padding: 0.05in 0.1in; width: 115.15pt;" valign="top" width="154"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">CHARACTERISTIC<o:p></o:p></span></b></p></td><td style="border-bottom: 1pt solid rgb(255, 255, 204); border-left: none; border-right: 1pt solid rgb(255, 255, 204); border-top: 2.25pt solid rgb(255, 255, 204); height: 39.75pt; padding: 0.05in 0.1in; width: 102.4pt;" valign="top" width="137"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a; font-size: 12pt; line-height: 18.4px;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MILD<o:p></o:p></span></b></p></td><td style="border-bottom: 1pt solid rgb(255, 255, 204); border-left: none; border-right: 1pt solid rgb(255, 255, 204); border-top: 2.25pt solid rgb(255, 255, 204); height: 39.75pt; padding: 0.05in 0.1in; width: 119.4pt;" valign="top" width="159"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #0070c0; font-size: 12pt; line-height: 18.4px;">MODERATE<o:p></o:p></span></b></p></td><td style="border-bottom: 1pt solid rgb(255, 255, 204); border-left: none; border-right: 2.25pt solid rgb(255, 255, 204); border-top: 2.25pt solid rgb(255, 255, 204); height: 39.75pt; padding: 0.05in 0.1in; width: 98.1pt;" valign="top" width="131"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b050; font-size: 12pt; line-height: 18.4px;">SEVERE<o:p></o:p></span></b></p></td></tr><tr style="height: 77.6pt;"><td style="border-bottom: 2.25pt solid rgb(255, 255, 204); border-left: 1pt solid rgb(255, 255, 204); border-right: 1pt solid rgb(255, 255, 204); border-top: none; height: 77.6pt; padding: 0.05in 0.1in; width: 115.15pt;" valign="top" width="154"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">SIZE<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">DEPTH<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">INFILTRATE<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">SCLERA<o:p></o:p></span></b></p></td><td style="border-bottom: 2.25pt solid rgb(255, 255, 204); border-left: none; border-right: 1pt solid rgb(255, 255, 204); border-top: none; height: 77.6pt; padding: 0.05in 0.1in; width: 102.4pt;" valign="top" width="137"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a; font-size: 12pt; line-height: 18.4px;">&lt;2mm<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a; font-size: 12pt; line-height: 18.4px;">&lt;20%<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a; font-size: 12pt; line-height: 18.4px;">SUPERFICIAL&nbsp;&nbsp;<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #e36c0a; font-size: 12pt; line-height: 18.4px;">NOT INVOLVED<o:p></o:p></span></b></p></td><td style="border-bottom: 2.25pt solid rgb(255, 255, 204); border-left: none; border-right: 1pt solid rgb(255, 255, 204); border-top: none; height: 77.6pt; padding: 0.05in 0.1in; width: 119.4pt;" valign="top" width="159"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #0070c0; font-size: 12pt; line-height: 18.4px;">&nbsp;2-5 mm<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #0070c0; font-size: 12pt; line-height: 18.4px;">&nbsp;20 –50 %<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #0070c0; font-size: 12pt; line-height: 18.4px;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MID STROMAL<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #0070c0; font-size: 12pt; line-height: 18.4px;">NOT INVOLVED<o:p></o:p></span></b></p></td><td style="border-bottom: 2.25pt solid rgb(255, 255, 204); border-left: none; border-right: 2.25pt solid rgb(255, 255, 204); border-top: none; height: 77.6pt; padding: 0.05in 0.1in; width: 98.1pt;" valign="top" width="131"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b050; font-size: 12pt; line-height: 18.4px;">&gt;5mm<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b050; font-size: 12pt; line-height: 18.4px;">&gt;50 %<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b050; font-size: 12pt; line-height: 18.4px;">&nbsp;DEEPER<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b050; font-size: 12pt; line-height: 18.4px;">&nbsp;MAY BE<o:p></o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><span style="color: #00b050; font-size: 12pt; line-height: 18.4px;">INVOLVED<o:p></o:p></span></b></p></td></tr></tbody></table><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><span style="color: #231f20; font-size: 12pt; line-height: 18.4px;">&nbsp;</span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319713">PAPILLOEDEMA</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><table border="0" cellpadding="0" class="MsoNormalTable" style="width: 40%px;"><tbody><tr><td style="padding: 0.75pt; width: 19px;" valign="top" width="3%"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><b>1</b><o:p></o:p></p></td><td style="padding: 0.75pt;"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><a name="4-u1.0-B978-0-7020-4093-1..00019-7--o169"></a><b>Early</b><o:p></o:p></p></td></tr><tr><td style="padding: 0.75pt; width: 19px;" valign="top" width="3%"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><b>2<o:p></o:p></b></p></td><td style="padding: 0.75pt;"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><a name="4-u1.0-B978-0-7020-4093-1..00019-7--o171"></a><b>Established<o:p></o:p></b></p></td></tr><tr><td style="padding: 0.75pt; width: 19px;" valign="top" width="3%"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><b>3<o:p></o:p></b></p></td><td style="padding: 0.75pt;"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><a name="4-u1.0-B978-0-7020-4093-1..00019-7--o176"></a><b>Chronic<o:p></o:p></b></p></td></tr><tr><td style="padding: 0.75pt; width: 19px;" valign="top" width="3%"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><b>4<o:p></o:p></b></p></td><td style="padding: 0.75pt;"><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: normal; margin: 0in 0in 0.0001pt;"><a name="4-u1.0-B978-0-7020-4093-1..00019-7--o178"></a><b>Atrophic<o:p></o:p></b></p></td></tr></tbody></table><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319714">Stages of Filtering Bleb Infections</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in; text-indent: -0.25in;"><span style="font-family: Wingdings;">l<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;</span></span>Stage 1:&nbsp;</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 1in; text-indent: -0.25in;"><span style="font-family: &quot;Times New Roman&quot;, serif;">•<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Purulent bleb</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 1in; text-indent: -0.25in;"><span style="font-family: &quot;Times New Roman&quot;, serif;">•<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>+/- AC reaction</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in; text-indent: -0.25in;"><span style="font-family: Wingdings;">l<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;</span></span>Stage 2:&nbsp;</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 1in; text-indent: -0.25in;"><span style="font-family: &quot;Times New Roman&quot;, serif;">•<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Purulent bleb</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 1in; text-indent: -0.25in;"><span style="font-family: &quot;Times New Roman&quot;, serif;">•<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Moderate AC inflammation</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 0.5in; text-indent: -0.25in;"><span style="font-family: Wingdings;">l<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;</span></span>Stage 3:</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt 1in; text-indent: -0.25in;"><span style="font-family: &quot;Times New Roman&quot;, serif;">•<span style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; font-stretch: normal; font-variant-east-asian: normal; font-variant-numeric: normal; line-height: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>Endophthalmitis with marked AC reaction, vitritis</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319715">Grading system of atrophia and phthisis bulbi</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">I Atrophy bulbi without shrinkage</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">II Atrophia bulbi with shrinkage</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">III Atrophia bulbi with shrinkage and disorganization (phthisis bulbi)</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">IV Phthisis bulbi with intraocular ossification</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">V Phthisis bulbi with intraocular calcium deposition</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319716">posterior staphyloma</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt; text-align: justify;"><span style="font-family: Arial, sans-serif; font-size: 9pt; line-height: 13.8px;">A posterior staphyloma is a backward ectasia of the fundus, the hallmark being tessellation and pallor of the area involved (Figure3). Posterior staphyloma can be of five types[</span><a href="../DOS%20complete/00%20DOS%20ALL%20ARTICLES/Myopia-An-Overview.html#7" style="color: purple;"><span style="font-family: Arial, sans-serif; font-size: 9pt; line-height: 13.8px;">7</span></a><span style="font-family: Arial, sans-serif; font-size: 9pt; line-height: 13.8px;">]:-</span><span style="font-family: &quot;Times New Roman&quot;, serif; font-size: 12pt; line-height: 18.4px;"><o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt; text-align: justify;"><span style="font-family: Arial, sans-serif; font-size: 9pt; line-height: 13.8px;">Type 1- The area of tessellation and pallor includes the region of the optic disc and macula. It is the most common type</span><o:p></o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt; text-align: justify;"><span style="font-family: Arial, sans-serif; font-size: 9pt; line-height: 13.8px;">Type 2- includes the region of the macula</span><o:p></o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt; text-align: justify;"><span style="font-family: Arial, sans-serif; font-size: 9pt; line-height: 13.8px;">Type 3- involves the peri-papillary region</span><o:p></o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt; text-align: justify;"><span style="font-family: Arial, sans-serif; font-size: 9pt; line-height: 13.8px;">Type 4- extends nasally from the disc</span><o:p></o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt; text-align: justify;"><span style="font-family: Arial, sans-serif; font-size: 9pt; line-height: 13.8px;">Type 5- most rare and involves the fundus inferior to the optic disc</span><o:p></o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319717">Chorioretinal Laser coagulation Grades</a><o:p></o:p></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade 1/Light: Barely visible blanching of retinal pigment epithelium (RPE)</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade 2/Mild: Hazy, faint white retinal coagulation</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade 3/Moderate: Opaque, dirty white retinal coagulation</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Grade 4/Heavy: Dense white, chalky retinal coagulation</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319718">Ectropion Grading (Rubin et al)</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">grade 1 — the lower punctum just pointing upwards away from globe (punctal ectropion)</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">grade 2 — partial everted lower lid and visible scleral show</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">grade 3 — the presence of conjunctival hyperemia and gross mucosal thickening and</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">grade 4 — as for grade 3 with additional exposure keratitis</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Depending upon the degree of outrolling, ectropion can be divided into three grades.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">In grade I ectropion only punctum is everted.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">In grade II lid margin is everted and palpebral conjunctiva is visible,</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">In grade III the fornix is also visible.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><h3 style="break-after: avoid; color: blue; font-family: Calibri, sans-serif; font-size: 13pt; line-height: 19.9333px; margin: 12pt 0in 3pt 0.25in; text-indent: -0.25in;"><a name="_Toc373319719">Cortical Visual Impairment</a></h3><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><b><i>Roman-Lantzy phases<o:p></o:p></i></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Phase is a period in the resolution of CVI that indicates degree or severity of CVI.</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;"><o:p>&nbsp;</o:p></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Phase 1: building visual behavior</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Phase 2: integrating vision with function</p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 11pt; line-height: 16.8667px; margin: 0in 0in 10pt;">Phase 3: resolution of remaining CVI characteristics</p><div><br /></div>




<p style="color: orange">- compiled & published by Dr Dhaval Patel MD AIIMS</p>
<!-- ShareThis BEGIN --><div class="sharethis-inline-share-buttons"></div><!-- ShareThis END -->
<br>
           </div>
 </div><!-- .col-md-8 -->


 <div class="col-lg-3 sidebar pl-lg-5 ftco-animate">
<script async src="https://cse.google.com/cse.js?cx=8ff4eb218d78bd195"></script>
<div class="gcse-search" enableAutoComplete="true"></div>
 
<h6 style="color: orange";>Among Top 30 Ophthalmology Blog</h6>
  <a href="https://blog.feedspot.com/ophthalmology_blogs/" title="Ophthalmology Blogs"><img alt=" Ophthalmology Blogs" src="https://blog.feedspot.com/wp-content/uploads/2018/03/ophthalmology_216px.png?x77178" /></a>

<h6 style="color: orange";>Amazon's Deals</h6>
<a href="https://www.amazon.in/gp/goldbox/ref=as_li_ss_tl?ie=UTF8&amp;linkCode=ll2&amp;tag=dhavalb20-21&amp;linkId=8408426555e21c5ab9ce5ea2d359de50" class="block-20 img d-flex align-items-center" style="background-image: url('images/amazondeal.png');"></a>

<div class="categories">
                <h6 style="color: orange";>Categories</h6>
                <li><a href="unitwise.html">RPC Unitwise Collection<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="cornea.html">Cornea<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="oculoplasty.html">Oculoplasty<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="glaucoma.html">Glaucoma<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="retina.html">Retina<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="uvea.html">Uvea<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="neurophthalmology.html">Neuro-ophthalmology<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="strabismus.html">Strabismus<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="lens.html">Lens<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="basicsciences.html">Basic Sciences<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="misc.html">Miscellaneous Topics<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="downloads.html">Downloads<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="exclusive.html">Ophthalmology Explorer<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="videos.html">Ophthalmology Videos<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="journals.html">Free Journals<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="eyefun.html">Fun with Eyes<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="philosophy.html">My Philosophy<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="eyeinformation.html">Patient's Blog in English<span class="fa fa-chevron-right"></span></a></li>
                <li><a href="netragyan.html">Patient's Blog in Gujarati<span class="fa fa-chevron-right"></span></a></li>

               
</div>
</div>
</section>




      <footer class="ftco-footer">
      <div class="container">
        <div class="row mb-5">
          <div class="col-sm-12 col-md">
            <div class="ftco-footer-widget mb-4">
              <h2 class="ftco-heading-2 logo"><a href="sadbhaavclinic.com">Sadbhaav Clinic</a></h2>
              <p>Serving for Sight & Smile</p>
              <ul class="ftco-footer-social list-unstyled mt-2">
                <li class="ftco-animate"><a href="https://www.twitter.com/SadbhaavClinic/"><span class="fa fa-twitter"></span></a></li>
                <li class="ftco-animate"><a href="https://www.facebook.com/SadbhaavClinic/"><span class="fa fa-facebook"></span></a></li>
                <li class="ftco-animate"><a href="https://www.instagram.com/SadbhaavClinic/"><span class="fa fa-instagram"></span></a></li>
                <li class="ftco-animate"><a href="https://www.linkedin.com/company/SadbhaavClinic/"><span class="fa fa-linkedin"></span></a></li>
                <li class="ftco-animate"><a href="https://www.pinterest.com/SadbhaavClinic/"><span class="fa fa-pinterest"></span></a></li>
                <li class="ftco-animate"><a href="https://api.whatsapp.com/send?phone=917016912180&text=I+need+to+book+an+appointment"><span class="fa fa-whatsapp"></span></a></li>
                <li class="ftco-animate"><a href="https://www.youtube.com/channel/UCn8Oxy6CKxwi9PKAVVgWwcg?view_as=subscriber"><span class="fa fa-youtube"></span></a></li>
              </ul>
            </div>
          </div>
          <div class="col-sm-12 col-md">
            <div class="ftco-footer-widget mb-4 ml-md-4">
              <h2 class="ftco-heading-2">Medical Associations</h2>
              <ul class="list-unstyled">
                <li><a href="https://www.aao.org/"><span class="fa fa-chevron-right mr-2"></span>AAO</a></li>
                <li><a href="https://www.ascrs.org/"><span class="fa fa-chevron-right mr-2"></span>ASCRS</a></li>
                <li><a href="https://www.escrs.org/"><span class="fa fa-chevron-right mr-2"></span>ESCRS</a></li>
                <li><a href="https://www.aios.org/"><span class="fa fa-chevron-right mr-2"></span>AIOS</a></li>
                <li><a href="https://www.ahmedabadophthalmologicalsociety.org/"><span class="fa fa-chevron-right mr-2"></span>AOS</a></li>
                <li><a href="https://ahmedabadmedicalassociation.com/"><span class="fa fa-chevron-right mr-2"></span>AMA</a></li>
              </ul>
            </div>
          </div>
              <div class="col-sm-12 col-md">
             <div class="ftco-footer-widget mb-4">
              <h2 class="ftco-heading-2">Empanelment</h2>
              <ul class="list-unstyled">
                <li><a href="https://www.ongcindia.com/wps/wcm/connect/ongcindia/home/"><span class="fa fa-chevron-right mr-2"></span>ONGC</a></li>            
              </ul>
              <h2 class="ftco-heading-2">Ophthalmology Blog</h2>
              <ul class="list-unstyled">
                <li><a href="ophthalmology.html"><span class="fa fa-chevron-right mr-2"></span>RPC Rounds</a></li>           
              </ul>
            </div>
          </div>
          <div class="col-sm-12 col-md">
            <div class="ftco-footer-widget mb-4 ml-md-4">
              <h2 class="ftco-heading-2">Patients' Zone</h2>
              <ul class="list-unstyled">
                <li><a href="testimonials.html"><span class="fa fa-chevron-right mr-2"></span>Join us</a></li>
                <li ><a href="clinicupdates.html"><span class="fa fa-chevron-right mr-2"></span>Clinic Updates</a></li>
                <li ><a href="netragyan.html"><span class="fa fa-chevron-right mr-2"></span>નેત્ર-જ્ઞાન</a></li>
                <li ><a href="eyeinformation.html"><span class="fa fa-chevron-right mr-2"></span>Eye Information</a></li>
              </ul>
            </div>
          </div>

          <div class="col-sm-12 col-md">
            <div class="ftco-footer-widget mb-4">
              <h2 class="ftco-heading-2">Have a Questions?</h2>
              <div class="block-23 mb-3">
                <ul>

                  <li><span class="icon fa fa-map-marker"></span><a href="https://g.page/SadbhaavEyeDentalClinic?share"> <span class="text">SF 5-6, Second Floor, Palladium Business Hub, Opposite PVR Cinema, Above Pantaloons, Visat-Gandhinagar Highway, Motera, Ahmedabad - 380005, India.</span></a></li>
                  <li><a href="tel:+917016912180"><span class="icon fa fa-phone"></span><span class="text">+91 701-691-2180</span></a></li>
                  <li><a href="mailto:sadbhaavclinic@gmail.com"><span class="icon fa fa-paper-plane pr-4"></span><span class="text">sadbhaavclinic@gmail.com</span></a></li>
                </ul>
              </div>
            </div>
          </div>
        </div>
      </div>
      
    </footer>
    
  

    
  

  <!-- loader -->
  <div id="ftco-loader" class="show fullscreen"><svg class="circular" width="48px" height="48px"><circle class="path-bg" cx="24" cy="24" r="22" fill="none" stroke-width="4" stroke="#eeeeee"/><circle class="path" cx="24" cy="24" r="22" fill="none" stroke-width="4" stroke-miterlimit="10" stroke="#F96D00"/></svg></div>


  <script src="js/jquery.min.js"></script>
  <script src="js/jquery-migrate-3.0.1.min.js"></script>
  <script src="js/popper.min.js"></script>
  <script src="js/bootstrap.min.js"></script>
  <script src="js/jquery.easing.1.3.js"></script>
  <script src="js/jquery.waypoints.min.js"></script>
  <script src="js/jquery.stellar.min.js"></script>
  <script src="js/owl.carousel.min.js"></script>
  <script src="js/jquery.magnific-popup.min.js"></script>
  <script src="js/jquery.animateNumber.min.js"></script>
  <script src="js/scrollax.min.js"></script>
  <script src="js/main.js"></script>
    
  </body>
</html>